Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 15Pain 13Pain, Postoperative 12Depression 9Breast Neoplasms 9Agnosia 9Head and Neck Neoplasms 6Anxiety Disorders 6Chronic Pain 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Acute Pain 4Pancreatic Neoplasms 3Pain, Intractable 3Lymphoma, Follicular 3Colorectal Neoplasms 3Prostatic Neoplasms 2Mucositis 2Gastrointestinal Neoplasms 2Colonic Neoplasms 2Cancer Pain 2Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1Stomatitis 1Spinal Stenosis 1Sezary Syndrome 1Rectal Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Analgesia 1Polycythemia Vera 1

Interventions

Paclitaxel 8Oxaliplatin 6Carboplatin 5Vincristine 4Radiotherapy 4Mental Status and Dementia Tests 4Leucovorin 4Amifostine 4Taxes 3Sodium Chloride 3Procarbazine 3Methotrexate 3Magnetic Resonance Spectroscopy 3Fluorouracil 3Cytarabine 3Cyclophosphamide 3Cisplatin 3xaliproden 2glucarpidase 2Surveys and Questionnaires 2Rituximab 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Psychiatric Rehabilitation 2Prednisolone 2Magnesium Sulfate 2Folfox protocol 2Duloxetine Hydrochloride 2Doxorubicin 2Dexamethasone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurotoxicity Syndromes × Ketamine × Clear all
NCT00471445 2015-11-09

Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients

University of Rochester

Phase 3 Completed
462 enrolled 14 charts

Pain, Peripheral Nervous System Diseases, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡